NCT01514630View on ClinicalTrials.gov

Creatine as a Treatment Option for Depression in Methamphetamine Using Females

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
DepressionSubstance AbuseSubstance UseNeuroimagingDual Diagnosis
Interventions
DRUG

Creatine monohydrate

Five grams of creatine monohydrate will be administered for eight weeks.

Trial Locations (1)

84108

The Brain Institute of the University of Utah, Salt Lake City

All Listed Sponsors
lead

Perry Renshaw

OTHER

NCT01514630 - Creatine as a Treatment Option for Depression in Methamphetamine Using Females | Biotech Hunter | Biotech Hunter